Results 61 to 70 of about 104,468 (212)

Myocarditis Following Inactivated SARS-CoV-2 Vaccine (Vero Cell) in an Adult Female in Vietnam: A Case Report

, 2023
Hoa Tran,1 Vu Hoang Vu,1 Duc Tran,2 Quang Dang Duy Pham,2 Khang Duong Nguyen,2 Binh Quang Truong1 1Department of Internal Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam; 2Cardiovascular Center, University ...
Vu VH, Tran D, Truong BQ, Tran H, Nguyen KD, Pham QDD   +5 more
core  

Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin.

, 2009
BACKGROUND: An association was previously established between facial nerve paralysis (Bell's palsy) and intranasal administration of an inactivated influenza virosome vaccine containing an enzymatically active Escherichia coli Heat Labile Toxin (LT ...
Kromann Ingrid, Woodrow, M, Novicki Deborah, Huo, Z, Del Giudice Giuseppe, Novicki, D, Rappuoli Rino, Thierry-Carstensen, B, Susan Barnett, Galiza, E, David J M Lewis, Rafaela Giemza, Andersen, P, Peter Andersen, Lewis David J. M., Barnett Susan, Maria Woodrow, Kromann, I, Giuseppe Del Giudice, Thierry-Carstensen Birgit, Giemza Rafaela, Ingrid Kromann, Andersen Peter, Lewis, DJ, Galiza Eva, Giemza, R, Huo Zhiming, Woodrow Maria, Deborah Novicki, Eva Galiza, Birgit Thierry-Carstensen, Rino Rappuoli, Del Giudice, G, Rappuoli, R, Barnett, S, Zhiming Huo   +35 more
core   +1 more source

Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance [PDF]

, 2009
BACKGROUND: Cholera remains a serious public health problem in low-income countries despite efforts in the past to promote oral rehydration therapy as major treatment.
Khatib Ahmed M, Al Pach, Khatib, Ahmed M, Claire-Lise Chaignat, Schaetti, C., Ali Said M, Weiss, M. G., Hutubessy, Raymond, Weiss, Mitchell G, Khatib, A. M., Mitchell G Weiss, Hutubessy Raymond, Schaetti Christian, Ahmed M Khatib, Ali, S. M., Schaetti, Christian, Chaignat Claire-Lise, Ali, Said M, Pach, Al, Pach Al, Pach, A., Chaignat, Claire-Lise, Hutubessy, R., Chaignat, C. L., Raymond Hutubessy, Weiss Mitchell G, Christian Schaetti, Said M Ali   +27 more
core   +1 more source

REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF DOMESTIC FLU-M INACTIVATED SPLIT INFLUENZA VACCINE FOR THE IMMUNIZATION OF ADULTS AGED BETWEEN 18 AND 60

Журнал микробиологии, эпидемиологии и иммунобиологии, 2018
Aim. The research was aimed at evaluating the reactogenicity, safety and immunogenicity of Flu-M inactivated split influenza vaccine. Materials and methods.
I. V. Feldblyum, K. A. Subbotina, S. D. Novgorodova, G. M. Ignatev, M. Kh. Alyeva, M. K. Erofeeva, V. G. Orlovsky, I. A. Leneva, S. Ya. Melnikov, E. V. Kazakova, E. P. Nacharova, V. P. Trukhin   +11 more
doaj   +1 more source

Efficacy of inactivated BEF vaccine adjuvant with Montanide ISA 206 compared with the locally prepared inactivated BEF vaccines [PDF]

Benha Veterinary Medical Journal, 2016
Bovine ephemeral fever (BEF) virus belonging to Ephemerovirus genus of the Rhabdoviridae family causes aneconomically important seasonal acute vector- borne disease.
Nermeen S., Amal M., El-Habbaa S., El-Bagoury F.   +3 more
doaj   +1 more source

Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study

, 2010
Objectives: To compare the safety, reactogenicity, and immunogenicity of an adjuvanted split virion H1N1 vaccine and a non-adjuvanted whole virion vaccine used in the pandemic immunisation programme in the United Kingdom.
Sheasby, E, Faust, S N, Okike, I, Miller, E., Casey, M., Walker, W T, Sheasby, E., Waight, P., Ladhani, S., Allen, R.J., Andrews, N, Eccleston, P.E., Faust, S.N., Oeser, C, John, T, Snape, MD, Pollard, AJ, Pollard, Andrew, Finn, A., Casey, M, Waddington, CS, Heath, PT, Heath, P.T., Collinson, AC, Eccleston, P E, Waddington, Claire S, Wilkins, S, Allen, R J, Faust, SN, Walker, W.T., Reiner, A, Ladhani, S, Collinson, A.C., Okike, I., Reiner, A., Waddington, Claire S., Miller, E, Andrews, N., Allen, RJ, Finn, A, Wilkins, S., Snape, M.D., Pollard, A.J., Eccleston, PE, Collinson, A C, Walker, WT, Heath, P T, Snape, M D, Hoschler, K., John, T., Hoschler, K, Waight, P, Oeser, C.   +52 more
core   +1 more source

A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity [PDF]

, 2012
© 2012 Elsevier Ltd. All rights reservedBackground: The development of a new, more effective vaccine against tuberculosis (TB) for use in healthy and HIV-infected adults, children and infants, remains a global health priority.
Minassian, Angela M, Porter, David W, Pathan, Ansar A, Rowland, Rosalind, Sander, C, Satti, Iman, Angela M Minassian, Nicola Williams, Lawrie, AM, Sander, Clare, Alison M Lawrie, Rowland, R, Poulton, ID, Rosalind Rowland, Brittain, N, Williams, Nicola, Pathan, AA, David W Porter, Minassian, AM, Helen McShane, Iman Satti, Ansar A Pathan, Ian D Poulton, Lawrie, Alison M, Nathaniel Brittain, Williams, N, Brittain, Nathaniel, Poulton, Ian D, Clare Sander, Porter, DW, Satti, I, McShane, H, McShane, Helen   +32 more
core   +1 more source

Efficacy of H2O2 inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine in mice

BMC Veterinary Research
Background Bovine viral diarrhea (BVD) is an acute febrile infectious disease caused by the bovine viral diarrhea virus (BVDV), which has brought huge economic losses to the world's cattle industry.
Cunyuan Li, Jinming Yu, Yue Wang, Xiaoyue Li, Yaxin Li, Mingxuan An, Wei Ni, Kaiping Liu, Shengwei Hu   +8 more
doaj   +1 more source

Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom

, 2013
An analysis was undertaken to measure age-specific vaccine effectiveness (VE) of 2010/11 trivalent seasonal influenza vaccine (TIV) and monovalent 2009 pandemic influenza vaccine (PIV) administered in 2009/2010.
Ellis, J., Fleming, D.M., Pebody, R.G., Andrews, Nick, Zambon, Maria, McMenamin, J., Moore, C., Hearns, C., Carman, W., Cottrell, S., Smyth, B., Durnall, H., Watson, J.M., Robertson, Chris, Sebastian-Pillai, P., Thomas, D.R.   +15 more
core   +1 more source

Immunization with an adjuvanted low-energy electron irradiation inactivated respiratory syncytial virus vaccine shows immunoprotective activity in mice

, 2022
S.1561-1569Respiratory syncytial virus (RSV) is a pathogen causing severe lower respiratory tract disease in infants and the elderly. In spite of the great need for a vaccine against RSV, currently there is no licensed product on the market. A very early
Bayer, Lea, Grunwald, Thomas, Ulbert, Sebastian, Fertey, Jasmin   +3 more
core   +1 more source